详情页

当前位置：首页 > 详情页

Efficacy and safety of oral poly (ADP-ribose) polymerase inhibitor fluzoparib in patients with BRCA1/2 mutations and platinum sensitive recurrent ovarian cancer

文献详情

资源类型：

WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：

机构： [1]Department of Gynecologic Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China [2]Department of Gynecologic Oncology, Qilu Hospital of Shandong University, Shandong, China [3]Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China [4]Department of Gynecologic Oncology, Chongqing Cancer Hospital, Chongqing, China [5]Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, China [6]Department of Gynecological Chemotherapy, West China Second University Hospital, Sichuan University, Chengdu, China [7]Department of Gynecologic Oncology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China [8]Gynaecological Cancer, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China [9]Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China [10]Gynaecological Cancer, Zhejiang University School of Medicine Sir Run Run Shaw Hospital, Zhejiang, China [11]Department of Gynecologic Oncology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China [12]Department of Gynecologic Oncology, Jiangsu Cancer Hospital, Nanjing, China [13]Gynaecological Cancer, The First Affiliated Hospital of Anhui Medical University, Hefei, China [14]Gynaecological Cancer, Fourth Hospital of Hebei Medical University, Shijiazhuang, China [15]Department of Gynecologic Oncology, Shanghai Frist Maternity and Infant Hospital, Shanghai, China [16]Gynaecological Cancer, The First Affiliated Hospital of Xi’an Jiaotong University, Xian, China [17]Jiangsu Hengrui Medicine Co. Ltd., Shanghai, China

出处：

ISSN：

基金：

语种：

被引次数：

WOS：

中科院分区：

出版当年[2019]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2025]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2019]版：

Q1 ONCOLOGY

最新[2024]版：

Q1 ONCOLOGY

影响因子： 65.4 最新[2024版] 46.8 最新五年平均 18.274 出版当年[2019版] 15.254 出版当年五年平均 14.196 出版前一年[2018版] 32.976 出版后一年[2020版]

第一作者：

第一作者机构： [1]Department of Gynecologic Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

推荐引用方式(GB/T 7714)：

APA：

MLA：